We are speaking at the 3rd GLOBAL XDC INNOVATION CONFERENCE in WuXi (CHINA)!
We are speaking at the 3rd GLOBAL XDC INNOVATION CONFERENCE in WuXi (CHINA) partnering event in WuXi (CHINA) , 10 – 12 Sep. 2024 We look forward to your presence to explore future partnership opportunities. * * * * * Contact: Valsasina Barbara : Barbara.Valsasina@demo111.axxiem.com Lupi Rosita: rosita.lupi@demo111.axxiem.com * * * * * About NMS […]
Present Scenario and Future Landscape of Payloads for ADCs: Focus on DNA-Interacting Agents
Valsasina B., Orsini P., Terenghi C., Ocana A. Pharmaceuticals 2024, 17, 1338.
Visible Light Promoted Site-Specific Functionalization of α-Acyloxy Carboxamides: Unlocking a Forbidden Chemical Space in the Passerini Reaction
Brunelli F, Quartieri F, Miletto I, Pulici M, Papeo G, Tron GC Chemistry (2024), 5;30(50), e202402175
Discovery and optimization of 4-pyrazolyl-2-aminopyrimidine derivatives as potent spleen tyrosine kinase (SYK) inhibitors
Cervi G, D’Alessio R, Bindi S, Buffa L, Burocchi A, Canevari G, Modugno M, Motto I, Saturno G, Orsini P Eur J Med Chem (2024), 270, 116375
Photocatalytic radical coupling of organoborates with α-Halogenated electron-poor olefins
Caldarelli M, Rezzi SJ, Colombo N, Pirali T, Papeo G J Org Chem (2024), 5, 89(1), 633-643
A novel platform of diversified cytotoxins and targeted payloads to drive ADC innovation
P. Orsini, M. Salsa, S. Rizzi, U. Cucchi, D. Faiardi, A. Burocchi, A. Ciavolella, R. Lupi, F. Gasparri, B. Valsasina AACR Annual Meeting 2024; April 5-10, 2024; San Diego –Abstract 5805 Cancer Res (2024) 84 (6_Supplement)
The MPS1/TTK inhibitor, NMS-01940153, synergizes with tisotumab vedotin in colorectal cancer
G. Texido, F. Gasparri, A. Ciavolella, L. Gianellini, A. Burocchi, I. Fraietta, A.E. Pedersen, A. Ocaña, R. Colombo, D. Roberti, L. Mahnke, C. Perrera AACR Annual Meeting 2024; April 5-10, 2024; San Diego –Abstract 509 Cancer Res (2024) 84 (6_Supplement)
Development of 14-amino-anthracyclines as novel payloads for ADC production showing potent anti-tumor activity and improved safety profile
P. Orsini, M. Salsa, A. Burocchi, A. Ciavolella, U. Cucchi, D. Faiardi, S. Rizzi, F. Gasparri, B. Valsasina 38th National Medicinal Chemistry Symposium; June 23-26, 2024; Seattle, WA.
A payload-linker generating machine to quickly move from small molecules to characterized tool ADCs and PDCs
R. Lupi, P. Orsini, M. Salsa, S. Rizzi, U. Cucchi, D. Faiardi, A. Burocchi, A. Ciavolella, F. Gasparri, B. Valsasina 14th World ADC London 2024; March 12-15, 2024; London, UK
Discovery of NMS-0963, a potent, selective and orally available Syk inhibitor with outstanding preclinical activity in diffuse large B-cell lymphoma
L. Buffa, G. Cervi, R. D’Alessio, S. Bindi, A. Burocchi, G. Canevari, M. Modugno, I. Motto, G. Saturno, P. Orsini 58th International Conference on Medicinal Chemistry (RICT 2024); July 3-5, 2024; Bordeaux, France
